Restech acquires Mederi Medical

Medtech developer Respiratory Technology Corp said today it acquired Mederi Therapeutics, and its Stretta catheter and Secca system, for an undisclosed amount. Houston-based Restech said that the addition of the Stretta catheter, designed to treat gastroesophageal reflux disease, and the Secca system, designed to treat bowel incontinence, are complimentary to its existing diagnostic devices. Mederi’s Stretta catheter system is designed to apply low-power radio frequency energy to remodel the lower esophageal sphincter to restore natural barrier function and reduce spontaneous regurgitation caused by transient relaxations of the sphincter. The Secca device uses a low-power radiofrequency generator to remodel the muscle of the internal anal sphincter to treat bowel incontinence, the company said. The Stretta and Secca devices will continue to be sold through Mederi RF, which will serve as a wholly-owned subsidiary of Restech. Restech has not yet announced which staff will join Restech’s management team with the acquisition. “This acquisition provides a unique opportunity to expand our reach across the clinical spectrum. With the addition of Mederi’s technology and market penetration, and Restech’s established space in the reflux market, these complementary products will address gaps in the clinical continuum,” CEO Debra Krahel said in a prepared sattement. The post Restech acquires Mederi Medical appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Catheters Mergers & Acquisitions Mederi Therapeutics respiratorytechnologycorp Source Type: news

Related Links:

Gastrointestinal (GI) motility disorders are major contributing factors to functional GI diseases that account for>40% of patients seen in gastroenterology clinics and affect>20% of the general population. The autonomic and enteric nervous systems and the muscles within the luminal GI tract have key roles in motility. In health, this complex integrated system works seamlessly to transport liquid, solid, and gas through the GI tract. However, major and minor motility disorders occur when these systems fail. Common functional GI motility disorders include dysphagia, gastroesophageal reflux disease, functional dyspepsia...
Source: Cold Spring Harbor perspectives in medicine - Category: Research Authors: Tags: Bioelectronic Medicine TECHNIQUES Source Type: research
Publication date: September 2019Source: Epilepsy &Behavior, Volume 98, Part AAuthor(s): Alessandro Graziosi, Noemi Pellegrino, Vincenzo Di Stefano, Umberto Raucci, Anna Luchetti, Pasquale ParisiAbstractPanayiotopoulos syndrome (PS) is a frequent (6% among children of 1–15 years) and benign epileptic syndrome, characterized by predominantly autonomic symptoms (emesis, pallor, flushing, cyanosis, mydriasis/miosis, cardiorespiratory and thermoregulatory alterations, incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility) associated with simple motor focal seizures, which can ...
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
Abstract Panayiotopoulos syndrome (PS) is a frequent (6% among children of 1-15 years) and benign epileptic syndrome, characterized by predominantly autonomic symptoms (emesis, pallor, flushing, cyanosis, mydriasis/miosis, cardiorespiratory and thermoregulatory alterations, incontinence of urine and/or feces, hypersalivation, and modifications of intestinal motility) associated with simple motor focal seizures, which can be followed by secondary generalization. Panayiotopoulos syndrome can be extremely insidious, because it can mimic several condition, such as gastroenteritis, gastroesophageal reflux disease, en...
Source: Epilepsy and Behaviour - Category: Neurology Authors: Tags: Epilepsy Behav Source Type: research
Conclusion Late-presented PUVs may be missed on VCUG. Whether a PUV might be present is crucial in boys with a history of recurrent urinary infection, persistent reflux, and repetitive daytime incontinence. Based on our results, we conclude that cystoscopic examination should be preferred for those cases to diagnose PUVs regardless of VCUG results. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: European Journal of Pediatric Surgery - Category: Surgery Authors: Tags: Original Article Source Type: research
We presented an interesting case with a 36-year-old man who's symptoms mimic acute prostatitis but there was no positive pathogen been cultured. The computed tomography (CT) findings revealed asymmetrical bladder wall thickening, which misleading us to the impression of bladder cancer. After the cystoscopy with bladder biopsy, the pathology revealed severe inflammation without malignancy. After that, we prescribed anticholinergic agent, beta-3 agonist and nonsteroidal anti-inflammatory drug (NSAID) for him, but in vain. Diagnoses: Erosive cystitis with prominent infiltration by eosinophils, lymphocytes, neutrophils and ...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
​​BY STUART ETENGOFF, DO, &ABDULLAH ​BOKHARI​, AB, DOA 20-year-old Caucasian man presented via EMS with a chief complaint of withdrawal from ketamine and secondary complaints of abdominal pain, blood in his urine, and painful urination with urgency for two days.He said he had been using ketamine intravenously daily for the past five days, up to 35 grams over the past week. His last use was 24 hours prior to presentation to the ED. He stated that he had been using ketamine regularly for four years and that he has used it intravenously, orally, and intranasally.He reported a history of ADHD and a family hist...
Source: The Case Files - Category: Emergency Medicine Tags: Blog Posts Source Type: research
Systemic Sclerosis (SSc) is a multisystem connective tissue disorder of unknown etiology. The gastrointestinal tract (GIT) is affected in about 90% of patients [1,2] and gut involvement is the leading cause of morbidity and the third most common cause of mortality in these patients [3]. Any part of the GIT can be affected, leading to a wide range of symptoms from gastro-esophageal reflux disease (GERD) to fecal incontinence [4 –7]. The GIT involvement in SSc has a negative impact on health-related quality of life (HRQOL) [8,9].
Source: Seminars in Arthritis and Rheumatism - Category: Rheumatology Authors: Source Type: research
Johnson &Johnson (NYSE:JNJ) subsidiary Ethicon said today it won FDA 510(k) clearance for its Echelon circular powered stapler. The company touted new features of the recently cleared stapler, saying it was designed to reduce anastomotic complications during colorectal, gastric and thoracic cancer surgeries. “Ethicon is committed to reducing complications, which have a significant impact on healthcare costs and patient outcomes. The Echelon Circular Powered Stapler addresses these challenges by combining powered firing with 2 staple forming innovations that reduce leaks without compromising perfusion,”...
Source: Mass Device - Category: Medical Equipment Authors: Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Surgical Ethicon Johnson & Johnson Source Type: news
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. InVivo wins Health Canada nod for cervical neuro-spinal scaffold trial InVivo Therapeutics said today it won Health Canada approval to initiate a clinical study of its neuro-spinal scaffold in patients with acute, complete AIS ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news
Johnson &Johnson (NYSE:JNJ) subsidiary Ethicon said today it closed its acquisition of Torax Medical, and its Linx acid reflux treatment portfolio, for an undisclosed amount. The Linx system from Shoreview, Minn.-based Torax is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients with gastro-esophageal reflux disease. Torax is also developing a similar device, Fenix, designed to treat fecal incontinence. “Torax and Ethicon share a vision for the transformational role that our products can have ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Mergers & Acquisitions Otolaryngology Ear, Nose & Throat Ethicon Johnson & Johnson Torax Medical Inc. Source Type: news
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Incontinence | Mergers and Aquisitions | Respiratory Medicine